nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—Fluoxymesterone—breast cancer	0.308	1	CrCtD
Norethindrone—PGR—breast cancer	0.0691	0.356	CbGaD
Norethindrone—SHBG—breast cancer	0.0646	0.333	CbGaD
Norethindrone—SHBG—Fluoxymesterone—breast cancer	0.054	0.276	CbGbCtD
Norethindrone—Formestane—Exemestane—breast cancer	0.032	0.167	CrCrCtD
Norethindrone—Stanozolol—Fluoxymesterone—breast cancer	0.0307	0.16	CrCrCtD
Norethindrone—Oxandrolone—Fluoxymesterone—breast cancer	0.0249	0.129	CrCrCtD
Norethindrone—CYP3A4—breast cancer	0.0223	0.115	CbGaD
Norethindrone—ALB—breast cancer	0.0194	0.1	CbGaD
Norethindrone—ABCB1—breast cancer	0.0185	0.0956	CbGaD
Norethindrone—Danazol—Fluoxymesterone—breast cancer	0.0169	0.0882	CrCrCtD
Norethindrone—Testosterone—Exemestane—breast cancer	0.0155	0.0809	CrCrCtD
Norethindrone—Cortisone acetate—Fluoxymesterone—breast cancer	0.0143	0.0744	CrCrCtD
Norethindrone—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0124	0.0646	CrCrCtD
Norethindrone—Progesterone—Fluoxymesterone—breast cancer	0.0124	0.0646	CrCrCtD
Norethindrone—Methyltestosterone—Fluoxymesterone—breast cancer	0.0121	0.063	CrCrCtD
Norethindrone—Testosterone—Fluoxymesterone—breast cancer	0.0108	0.0561	CrCrCtD
Norethindrone—Hydrocortisone—Fluoxymesterone—breast cancer	0.0101	0.0527	CrCrCtD
Norethindrone—CYP3A5—Lapatinib—breast cancer	0.0075	0.0383	CbGbCtD
Norethindrone—ABCB1—Toremifene—breast cancer	0.00669	0.0342	CbGbCtD
Norethindrone—CYP2C19—Lapatinib—breast cancer	0.00605	0.0309	CbGbCtD
Norethindrone—CYP3A4—Exemestane—breast cancer	0.00578	0.0295	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.005	0.0256	CbGbCtD
Norethindrone—CYP3A7—Tamoxifen—breast cancer	0.005	0.0256	CbGbCtD
Norethindrone—CYP3A4—Letrozole—breast cancer	0.00492	0.0251	CbGbCtD
Norethindrone—ABCB1—Lapatinib—breast cancer	0.00488	0.0249	CbGbCtD
Norethindrone—CYP3A4—Anastrozole—breast cancer	0.00438	0.0224	CbGbCtD
Norethindrone—CYP3A4—Toremifene—breast cancer	0.00401	0.0205	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00389	0.0199	CbGbCtD
Norethindrone—CYP3A7—Paclitaxel—breast cancer	0.00389	0.0199	CbGbCtD
Norethindrone—CYP3A7—Irinotecan—breast cancer	0.00384	0.0196	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00384	0.0196	CbGbCtD
Norethindrone—CYP3A5—Tamoxifen—breast cancer	0.00375	0.0192	CbGbCtD
Norethindrone—CYP3A4—Fulvestrant—breast cancer	0.00373	0.019	CbGbCtD
Norethindrone—ALB—Irinotecan—breast cancer	0.00359	0.0183	CbGbCtD
Norethindrone—ALB—Fluorouracil—breast cancer	0.00344	0.0176	CbGbCtD
Norethindrone—CYP3A4—Thiotepa—breast cancer	0.00332	0.017	CbGbCtD
Norethindrone—CYP3A4—Ixabepilone—breast cancer	0.00304	0.0155	CbGbCtD
Norethindrone—PGR—corpus luteum—breast cancer	0.00303	0.298	CbGeAlD
Norethindrone—CYP2C19—Tamoxifen—breast cancer	0.00303	0.0155	CbGbCtD
Norethindrone—CYP3A4—Lapatinib—breast cancer	0.00292	0.0149	CbGbCtD
Norethindrone—CYP3A5—Paclitaxel—breast cancer	0.00292	0.0149	CbGbCtD
Norethindrone—CYP3A5—Irinotecan—breast cancer	0.00288	0.0147	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00282	0.0144	CbGbCtD
Norethindrone—CYP3A7—Docetaxel—breast cancer	0.00282	0.0144	CbGbCtD
Norethindrone—ABCB1—Vinorelbine—breast cancer	0.00271	0.0138	CbGbCtD
Norethindrone—ABCB1—Tamoxifen—breast cancer	0.00244	0.0125	CbGbCtD
Norethindrone—ABCB1—Mitoxantrone—breast cancer	0.00238	0.0122	CbGbCtD
Norethindrone—CYP3A4—Raloxifene—breast cancer	0.00222	0.0113	CbGbCtD
Norethindrone—CYP3A5—Docetaxel—breast cancer	0.00211	0.0108	CbGbCtD
Norethindrone—ABCB1—Gemcitabine—breast cancer	0.0021	0.0108	CbGbCtD
Norethindrone—ABCB1—Paclitaxel—breast cancer	0.0019	0.00971	CbGbCtD
Norethindrone—ALB—Methotrexate—breast cancer	0.0019	0.00969	CbGbCtD
Norethindrone—ABCB1—Irinotecan—breast cancer	0.00188	0.00958	CbGbCtD
Norethindrone—ABCB1—Vinblastine—breast cancer	0.00167	0.00852	CbGbCtD
Norethindrone—CYP3A4—Vinorelbine—breast cancer	0.00162	0.00828	CbGbCtD
Norethindrone—CYP3A4—Tamoxifen—breast cancer	0.00146	0.00748	CbGbCtD
Norethindrone—CYP3A4—Mitoxantrone—breast cancer	0.00143	0.00729	CbGbCtD
Norethindrone—ABCB1—Docetaxel—breast cancer	0.00137	0.00702	CbGbCtD
Norethindrone—CYP3A4—Paclitaxel—breast cancer	0.00114	0.00582	CbGbCtD
Norethindrone—CYP3A4—Irinotecan—breast cancer	0.00112	0.00574	CbGbCtD
Norethindrone—ABCB1—Doxorubicin—breast cancer	0.00102	0.00523	CbGbCtD
Norethindrone—CYP3A4—Vinblastine—breast cancer	0.000999	0.0051	CbGbCtD
Norethindrone—ABCB1—Methotrexate—breast cancer	0.000993	0.00507	CbGbCtD
Norethindrone—CYP3A4—Docetaxel—breast cancer	0.000824	0.00421	CbGbCtD
Norethindrone—CYP3A4—Doxorubicin—breast cancer	0.000614	0.00314	CbGbCtD
Norethindrone—PGR—mammary gland—breast cancer	0.00047	0.0461	CbGeAlD
Norethindrone—ALB—mammary gland—breast cancer	0.000431	0.0423	CbGeAlD
Norethindrone—PGR—nipple—breast cancer	0.000389	0.0381	CbGeAlD
Norethindrone—CYP3A7—endocrine gland—breast cancer	0.000272	0.0267	CbGeAlD
Norethindrone—PGR—epithelium—breast cancer	0.000262	0.0257	CbGeAlD
Norethindrone—SHBG—endometrium—breast cancer	0.00026	0.0256	CbGeAlD
Norethindrone—SHBG—uterus—breast cancer	0.00024	0.0236	CbGeAlD
Norethindrone—SHBG—pituitary gland—breast cancer	0.000236	0.0231	CbGeAlD
Norethindrone—SHBG—adipose tissue—breast cancer	0.000235	0.023	CbGeAlD
Norethindrone—PGR—endometrium—breast cancer	0.000235	0.023	CbGeAlD
Norethindrone—PGR—uterus—breast cancer	0.000216	0.0212	CbGeAlD
Norethindrone—SHBG—female reproductive system—breast cancer	0.000216	0.0212	CbGeAlD
Norethindrone—PGR—pituitary gland—breast cancer	0.000212	0.0208	CbGeAlD
Norethindrone—PGR—adipose tissue—breast cancer	0.000211	0.0207	CbGeAlD
Norethindrone—SHBG—adrenal gland—breast cancer	0.000211	0.0207	CbGeAlD
Norethindrone—SHBG—bone marrow—breast cancer	0.000204	0.02	CbGeAlD
Norethindrone—SHBG—female gonad—breast cancer	0.000196	0.0193	CbGeAlD
Norethindrone—PGR—female reproductive system—breast cancer	0.000194	0.0191	CbGeAlD
Norethindrone—Fluoxymesterone—PRLR—breast cancer	0.00019	0.0793	CrCbGaD
Norethindrone—PGR—adrenal gland—breast cancer	0.00019	0.0186	CbGeAlD
Norethindrone—SHBG—endocrine gland—breast cancer	0.000183	0.0179	CbGeAlD
Norethindrone—PGR—female gonad—breast cancer	0.000177	0.0174	CbGeAlD
Norethindrone—ALB—adrenal gland—breast cancer	0.000174	0.0171	CbGeAlD
Norethindrone—PGR—endocrine gland—breast cancer	0.000164	0.0161	CbGeAlD
Norethindrone—CYP3A5—adipose tissue—breast cancer	0.000123	0.0121	CbGeAlD
Norethindrone—CYP2C19—endocrine gland—breast cancer	0.000121	0.0119	CbGeAlD
Norethindrone—PGR—lymph node—breast cancer	0.000114	0.0112	CbGeAlD
Norethindrone—ALB—lymph node—breast cancer	0.000104	0.0102	CbGeAlD
Norethindrone—CYP3A5—female gonad—breast cancer	0.000103	0.0101	CbGeAlD
Norethindrone—ABCB1—embryo—breast cancer	9.9e-05	0.00972	CbGeAlD
Norethindrone—CYP3A5—endocrine gland—breast cancer	9.56e-05	0.00939	CbGeAlD
Norethindrone—CYP3A4—female reproductive system—breast cancer	8.48e-05	0.00832	CbGeAlD
Norethindrone—Stanozolol—AR—breast cancer	8.13e-05	0.034	CrCbGaD
Norethindrone—ABCB1—epithelium—breast cancer	8.08e-05	0.00793	CbGeAlD
Norethindrone—Oxandrolone—AR—breast cancer	7.32e-05	0.0306	CrCbGaD
Norethindrone—ABCB1—endometrium—breast cancer	7.25e-05	0.00711	CbGeAlD
Norethindrone—CYP3A4—endocrine gland—breast cancer	7.18e-05	0.00704	CbGeAlD
Norethindrone—Ethynodiol—PGR—breast cancer	6.77e-05	0.0283	CrCbGaD
Norethindrone—ABCB1—uterus—breast cancer	6.68e-05	0.00655	CbGeAlD
Norethindrone—ABCB1—pituitary gland—breast cancer	6.56e-05	0.00644	CbGeAlD
Norethindrone—ABCB1—adipose tissue—breast cancer	6.53e-05	0.00641	CbGeAlD
Norethindrone—Norelgestromin—PGR—breast cancer	6.4e-05	0.0267	CrCbGaD
Norethindrone—Allylestrenol—PGR—breast cancer	6.4e-05	0.0267	CrCbGaD
Norethindrone—Desogestrel—PGR—breast cancer	6.16e-05	0.0257	CrCbGaD
Norethindrone—ABCB1—female reproductive system—breast cancer	6e-05	0.00589	CbGeAlD
Norethindrone—ABCB1—adrenal gland—breast cancer	5.86e-05	0.00575	CbGeAlD
Norethindrone—Norgestimate—PGR—breast cancer	5.76e-05	0.0241	CrCbGaD
Norethindrone—Desogestrel—SHBG—breast cancer	5.75e-05	0.024	CrCbGaD
Norethindrone—Nandrolone phenpropionate—AR—breast cancer	5.73e-05	0.0239	CrCbGaD
Norethindrone—ABCB1—bone marrow—breast cancer	5.67e-05	0.00556	CbGeAlD
Norethindrone—ABCB1—female gonad—breast cancer	5.46e-05	0.00536	CbGeAlD
Norethindrone—Quinestrol—ESR1—breast cancer	5.19e-05	0.0217	CrCbGaD
Norethindrone—ABCB1—endocrine gland—breast cancer	5.08e-05	0.00499	CbGeAlD
Norethindrone—Etonogestrel—PGR—breast cancer	4.98e-05	0.0208	CrCbGaD
Norethindrone—Testosterone Propionate—CYP17A1—breast cancer	4.89e-05	0.0204	CrCbGaD
Norethindrone—Nandrolone phenpropionate—CYP19A1—breast cancer	4.8e-05	0.02	CrCbGaD
Norethindrone—Etonogestrel—SHBG—breast cancer	4.66e-05	0.0194	CrCbGaD
Norethindrone—Nandrolone decanoate—AR—breast cancer	4.34e-05	0.0181	CrCbGaD
Norethindrone—Drospirenone—PGR—breast cancer	4.32e-05	0.018	CrCbGaD
Norethindrone—Ethynodiol—ESR1—breast cancer	4.28e-05	0.0179	CrCbGaD
Norethindrone—Allylestrenol—ESR1—breast cancer	4.04e-05	0.0169	CrCbGaD
Norethindrone—Testosterone Propionate—COMT—breast cancer	3.98e-05	0.0166	CrCbGaD
Norethindrone—Mestranol—ESR1—breast cancer	3.93e-05	0.0164	CrCbGaD
Norethindrone—Desogestrel—ESR1—breast cancer	3.89e-05	0.0162	CrCbGaD
Norethindrone—Norgestimate—ESR1—breast cancer	3.64e-05	0.0152	CrCbGaD
Norethindrone—Nandrolone decanoate—CYP19A1—breast cancer	3.64e-05	0.0152	CrCbGaD
Norethindrone—Drospirenone—AR—breast cancer	3.54e-05	0.0148	CrCbGaD
Norethindrone—Levonorgestrel—PGR—breast cancer	3.53e-05	0.0147	CrCbGaD
Norethindrone—ABCB1—lymph node—breast cancer	3.51e-05	0.00345	CbGeAlD
Norethindrone—Levonorgestrel—SHBG—breast cancer	3.29e-05	0.0138	CrCbGaD
Norethindrone—Danazol—PGR—breast cancer	3.21e-05	0.0134	CrCbGaD
Norethindrone—Etonogestrel—ESR1—breast cancer	3.15e-05	0.0131	CrCbGaD
Norethindrone—Fluoxymesterone—SHBG—breast cancer	3.14e-05	0.0131	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR2—breast cancer	3.04e-05	0.0127	CrCbGaD
Norethindrone—Danazol—SHBG—breast cancer	3e-05	0.0125	CrCbGaD
Norethindrone—Testosterone Propionate—AR—breast cancer	2.97e-05	0.0124	CrCbGaD
Norethindrone—Drospirenone—BCHE—breast cancer	2.96e-05	0.0124	CrCbGaD
Norethindrone—Levonorgestrel—AR—breast cancer	2.89e-05	0.0121	CrCbGaD
Norethindrone—Ethinyl Estradiol—SHBG—breast cancer	2.78e-05	0.0116	CrCbGaD
Norethindrone—Fluoxymesterone—AR—breast cancer	2.75e-05	0.0115	CrCbGaD
Norethindrone—Danazol—AR—breast cancer	2.63e-05	0.011	CrCbGaD
Norethindrone—Methyltestosterone—SHBG—breast cancer	2.54e-05	0.0106	CrCbGaD
Norethindrone—Levonorgestrel—CYP19A1—breast cancer	2.42e-05	0.0101	CrCbGaD
Norethindrone—Migraine—Doxorubicin—breast cancer	2.28e-05	0.000331	CcSEcCtD
Norethindrone—Affect lability—Doxorubicin—breast cancer	2.28e-05	0.000331	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Irinotecan—breast cancer	2.28e-05	0.000331	CcSEcCtD
Norethindrone—Fatigue—Irinotecan—breast cancer	2.28e-05	0.00033	CcSEcCtD
Norethindrone—Fatigue—Mitoxantrone—breast cancer	2.28e-05	0.00033	CcSEcCtD
Norethindrone—Vomiting—Goserelin—breast cancer	2.28e-05	0.00033	CcSEcCtD
Norethindrone—Alopecia—Docetaxel—breast cancer	2.27e-05	0.000329	CcSEcCtD
Norethindrone—Pruritus—Vinorelbine—breast cancer	2.27e-05	0.000329	CcSEcCtD
Norethindrone—Breast disorder—Epirubicin—breast cancer	2.27e-05	0.000328	CcSEcCtD
Norethindrone—Rash—Goserelin—breast cancer	2.26e-05	0.000327	CcSEcCtD
Norethindrone—Hypersensitivity—Thiotepa—breast cancer	2.26e-05	0.000327	CcSEcCtD
Norethindrone—Dermatitis—Goserelin—breast cancer	2.25e-05	0.000327	CcSEcCtD
Norethindrone—Mental disorder—Docetaxel—breast cancer	2.25e-05	0.000327	CcSEcCtD
Norethindrone—Somnolence—Fluorouracil—breast cancer	2.25e-05	0.000326	CcSEcCtD
Norethindrone—Immune system disorder—Capecitabine—breast cancer	2.25e-05	0.000326	CcSEcCtD
Norethindrone—Progesterone—CYP17A1—breast cancer	2.24e-05	0.00937	CrCbGaD
Norethindrone—Headache—Goserelin—breast cancer	2.24e-05	0.000325	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	2.23e-05	0.000324	CcSEcCtD
Norethindrone—Dyspepsia—Fluorouracil—breast cancer	2.23e-05	0.000323	CcSEcCtD
Norethindrone—Nausea—Tamoxifen—breast cancer	2.23e-05	0.000323	CcSEcCtD
Norethindrone—Levonorgestrel—ESR1—breast cancer	2.23e-05	0.0093	CrCbGaD
Norethindrone—Methyltestosterone—AR—breast cancer	2.22e-05	0.00929	CrCbGaD
Norethindrone—Gastrointestinal disorder—Gemcitabine—breast cancer	2.22e-05	0.000322	CcSEcCtD
Norethindrone—Fatigue—Gemcitabine—breast cancer	2.22e-05	0.000322	CcSEcCtD
Norethindrone—Danazol—CYP19A1—breast cancer	2.2e-05	0.0092	CrCbGaD
Norethindrone—Alopecia—Capecitabine—breast cancer	2.2e-05	0.000319	CcSEcCtD
Norethindrone—Mood swings—Doxorubicin—breast cancer	2.2e-05	0.000319	CcSEcCtD
Norethindrone—Asthenia—Thiotepa—breast cancer	2.2e-05	0.000318	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Fluorouracil—breast cancer	2.19e-05	0.000317	CcSEcCtD
Norethindrone—Abdominal distension—Epirubicin—breast cancer	2.18e-05	0.000316	CcSEcCtD
Norethindrone—Mental disorder—Capecitabine—breast cancer	2.18e-05	0.000316	CcSEcCtD
Norethindrone—Nausea—Melphalan—breast cancer	2.18e-05	0.000316	CcSEcCtD
Norethindrone—Pruritus—Thiotepa—breast cancer	2.17e-05	0.000314	CcSEcCtD
Norethindrone—Gastrointestinal pain—Mitoxantrone—breast cancer	2.16e-05	0.000313	CcSEcCtD
Norethindrone—Gastrointestinal pain—Irinotecan—breast cancer	2.16e-05	0.000313	CcSEcCtD
Norethindrone—Oedema—Paclitaxel—breast cancer	2.16e-05	0.000312	CcSEcCtD
Norethindrone—Anaphylactic shock—Paclitaxel—breast cancer	2.16e-05	0.000312	CcSEcCtD
Norethindrone—Flatulence—Capecitabine—breast cancer	2.14e-05	0.00031	CcSEcCtD
Norethindrone—Nausea—Goserelin—breast cancer	2.13e-05	0.000308	CcSEcCtD
Norethindrone—Fluoxymesterone—ESR1—breast cancer	2.12e-05	0.00886	CrCbGaD
Norethindrone—Dizziness—Vinorelbine—breast cancer	2.12e-05	0.000307	CcSEcCtD
Norethindrone—Photosensitivity reaction—Methotrexate—breast cancer	2.11e-05	0.000306	CcSEcCtD
Norethindrone—Urticaria—Mitoxantrone—breast cancer	2.1e-05	0.000304	CcSEcCtD
Norethindrone—Breast disorder—Doxorubicin—breast cancer	2.1e-05	0.000304	CcSEcCtD
Norethindrone—Skin disorder—Paclitaxel—breast cancer	2.09e-05	0.000303	CcSEcCtD
Norethindrone—Abdominal pain—Irinotecan—breast cancer	2.09e-05	0.000303	CcSEcCtD
Norethindrone—Abdominal pain—Mitoxantrone—breast cancer	2.09e-05	0.000303	CcSEcCtD
Norethindrone—Drowsiness—Methotrexate—breast cancer	2.07e-05	0.000299	CcSEcCtD
Norethindrone—Allylestrenol—CYP3A4—breast cancer	2.06e-05	0.00861	CrCbGaD
Norethindrone—Depression—Methotrexate—breast cancer	2.06e-05	0.000298	CcSEcCtD
Norethindrone—Vomiting—Vinorelbine—breast cancer	2.04e-05	0.000295	CcSEcCtD
Norethindrone—Progesterone—ABCC1—breast cancer	2.03e-05	0.0085	CrCbGaD
Norethindrone—Renal failure—Methotrexate—breast cancer	2.03e-05	0.000294	CcSEcCtD
Norethindrone—Danazol—ESR1—breast cancer	2.03e-05	0.00847	CrCbGaD
Norethindrone—Dizziness—Thiotepa—breast cancer	2.02e-05	0.000293	CcSEcCtD
Norethindrone—Rash—Vinorelbine—breast cancer	2.02e-05	0.000293	CcSEcCtD
Norethindrone—Dermatitis—Vinorelbine—breast cancer	2.02e-05	0.000293	CcSEcCtD
Norethindrone—Abdominal distension—Doxorubicin—breast cancer	2.02e-05	0.000293	CcSEcCtD
Norethindrone—Urticaria—Fluorouracil—breast cancer	2.01e-05	0.000291	CcSEcCtD
Norethindrone—Headache—Vinorelbine—breast cancer	2.01e-05	0.000291	CcSEcCtD
Norethindrone—Photosensitivity reaction—Epirubicin—breast cancer	1.98e-05	0.000287	CcSEcCtD
Norethindrone—Weight increased—Epirubicin—breast cancer	1.97e-05	0.000286	CcSEcCtD
Norethindrone—Hepatobiliary disease—Methotrexate—breast cancer	1.95e-05	0.000283	CcSEcCtD
Norethindrone—Insomnia—Paclitaxel—breast cancer	1.95e-05	0.000283	CcSEcCtD
Norethindrone—Hypersensitivity—Irinotecan—breast cancer	1.95e-05	0.000282	CcSEcCtD
Norethindrone—Hypersensitivity—Mitoxantrone—breast cancer	1.95e-05	0.000282	CcSEcCtD
Norethindrone—Vomiting—Thiotepa—breast cancer	1.95e-05	0.000282	CcSEcCtD
Norethindrone—Convulsion—Docetaxel—breast cancer	1.94e-05	0.000281	CcSEcCtD
Norethindrone—Drowsiness—Epirubicin—breast cancer	1.93e-05	0.00028	CcSEcCtD
Norethindrone—Rash—Thiotepa—breast cancer	1.93e-05	0.00028	CcSEcCtD
Norethindrone—Dermatitis—Thiotepa—breast cancer	1.93e-05	0.000279	CcSEcCtD
Norethindrone—Headache—Thiotepa—breast cancer	1.92e-05	0.000278	CcSEcCtD
Norethindrone—Somnolence—Paclitaxel—breast cancer	1.92e-05	0.000278	CcSEcCtD
Norethindrone—Hydrocortisone—SHBG—breast cancer	1.91e-05	0.00798	CrCbGaD
Norethindrone—Nausea—Vinorelbine—breast cancer	1.9e-05	0.000276	CcSEcCtD
Norethindrone—Renal failure—Epirubicin—breast cancer	1.9e-05	0.000275	CcSEcCtD
Norethindrone—Dyspepsia—Paclitaxel—breast cancer	1.9e-05	0.000275	CcSEcCtD
Norethindrone—Asthenia—Mitoxantrone—breast cancer	1.9e-05	0.000275	CcSEcCtD
Norethindrone—Asthenia—Irinotecan—breast cancer	1.9e-05	0.000275	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	1.89e-05	0.000274	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ESR1—breast cancer	1.88e-05	0.00783	CrCbGaD
Norethindrone—Hypersensitivity—Fluorouracil—breast cancer	1.87e-05	0.00027	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—breast cancer	1.86e-05	0.00027	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Paclitaxel—breast cancer	1.86e-05	0.00027	CcSEcCtD
Norethindrone—Methyltestosterone—CYP19A1—breast cancer	1.86e-05	0.00777	CrCbGaD
Norethindrone—Fatigue—Paclitaxel—breast cancer	1.86e-05	0.000269	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—breast cancer	1.85e-05	0.000269	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—breast cancer	1.85e-05	0.000269	CcSEcCtD
Norethindrone—Asthenia—Gemcitabine—breast cancer	1.85e-05	0.000268	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	1.83e-05	0.000266	CcSEcCtD
Norethindrone—Photosensitivity reaction—Doxorubicin—breast cancer	1.83e-05	0.000265	CcSEcCtD
Norethindrone—Hepatobiliary disease—Epirubicin—breast cancer	1.83e-05	0.000265	CcSEcCtD
Norethindrone—Oedema—Docetaxel—breast cancer	1.83e-05	0.000265	CcSEcCtD
Norethindrone—Anaphylactic shock—Docetaxel—breast cancer	1.83e-05	0.000265	CcSEcCtD
Norethindrone—Weight increased—Doxorubicin—breast cancer	1.83e-05	0.000264	CcSEcCtD
Norethindrone—Pruritus—Gemcitabine—breast cancer	1.82e-05	0.000264	CcSEcCtD
Norethindrone—Nausea—Thiotepa—breast cancer	1.82e-05	0.000263	CcSEcCtD
Norethindrone—Pruritus—Fluorouracil—breast cancer	1.79e-05	0.00026	CcSEcCtD
Norethindrone—Drowsiness—Doxorubicin—breast cancer	1.79e-05	0.000259	CcSEcCtD
Norethindrone—Skin disorder—Docetaxel—breast cancer	1.77e-05	0.000257	CcSEcCtD
Norethindrone—Oedema—Capecitabine—breast cancer	1.77e-05	0.000256	CcSEcCtD
Norethindrone—Gastrointestinal pain—Paclitaxel—breast cancer	1.76e-05	0.000255	CcSEcCtD
Norethindrone—Renal failure—Doxorubicin—breast cancer	1.76e-05	0.000255	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—breast cancer	1.75e-05	0.000254	CcSEcCtD
Norethindrone—Dizziness—Irinotecan—breast cancer	1.75e-05	0.000253	CcSEcCtD
Norethindrone—Haemoglobin—Epirubicin—breast cancer	1.74e-05	0.000253	CcSEcCtD
Norethindrone—Haemorrhage—Epirubicin—breast cancer	1.73e-05	0.000251	CcSEcCtD
Norethindrone—Hepatitis—Epirubicin—breast cancer	1.73e-05	0.000251	CcSEcCtD
Norethindrone—Skin disorder—Capecitabine—breast cancer	1.72e-05	0.000249	CcSEcCtD
Norethindrone—Urticaria—Paclitaxel—breast cancer	1.71e-05	0.000248	CcSEcCtD
Norethindrone—Connective tissue disorder—Epirubicin—breast cancer	1.7e-05	0.000247	CcSEcCtD
Norethindrone—Abdominal pain—Paclitaxel—breast cancer	1.7e-05	0.000247	CcSEcCtD
Norethindrone—Hepatobiliary disease—Doxorubicin—breast cancer	1.69e-05	0.000245	CcSEcCtD
Norethindrone—Vomiting—Mitoxantrone—breast cancer	1.68e-05	0.000244	CcSEcCtD
Norethindrone—Vomiting—Irinotecan—breast cancer	1.68e-05	0.000244	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—breast cancer	1.67e-05	0.000243	CcSEcCtD
Norethindrone—Dizziness—Fluorouracil—breast cancer	1.67e-05	0.000243	CcSEcCtD
Norethindrone—Rash—Irinotecan—breast cancer	1.67e-05	0.000242	CcSEcCtD
Norethindrone—Rash—Mitoxantrone—breast cancer	1.67e-05	0.000242	CcSEcCtD
Norethindrone—Dermatitis—Irinotecan—breast cancer	1.67e-05	0.000241	CcSEcCtD
Norethindrone—Dermatitis—Mitoxantrone—breast cancer	1.67e-05	0.000241	CcSEcCtD
Norethindrone—Progesterone—PGR—breast cancer	1.66e-05	0.00695	CrCbGaD
Norethindrone—Headache—Mitoxantrone—breast cancer	1.66e-05	0.00024	CcSEcCtD
Norethindrone—Headache—Irinotecan—breast cancer	1.66e-05	0.00024	CcSEcCtD
Norethindrone—Cortisone acetate—CYP3A4—breast cancer	1.65e-05	0.00691	CrCbGaD
Norethindrone—Insomnia—Docetaxel—breast cancer	1.65e-05	0.00024	CcSEcCtD
Norethindrone—Erythema multiforme—Epirubicin—breast cancer	1.64e-05	0.000238	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—breast cancer	1.64e-05	0.000237	CcSEcCtD
Norethindrone—Vomiting—Gemcitabine—breast cancer	1.64e-05	0.000237	CcSEcCtD
Norethindrone—Somnolence—Docetaxel—breast cancer	1.62e-05	0.000235	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—breast cancer	1.62e-05	0.000235	CcSEcCtD
Norethindrone—Rash—Gemcitabine—breast cancer	1.62e-05	0.000235	CcSEcCtD
Norethindrone—Dermatitis—Gemcitabine—breast cancer	1.62e-05	0.000235	CcSEcCtD
Norethindrone—Haemoglobin—Doxorubicin—breast cancer	1.61e-05	0.000234	CcSEcCtD
Norethindrone—Headache—Gemcitabine—breast cancer	1.61e-05	0.000234	CcSEcCtD
Norethindrone—Vomiting—Fluorouracil—breast cancer	1.61e-05	0.000233	CcSEcCtD
Norethindrone—Dyspepsia—Docetaxel—breast cancer	1.61e-05	0.000233	CcSEcCtD
Norethindrone—Etonogestrel—CYP3A4—breast cancer	1.61e-05	0.0067	CrCbGaD
Norethindrone—Hepatitis—Doxorubicin—breast cancer	1.61e-05	0.000233	CcSEcCtD
Norethindrone—Haemorrhage—Doxorubicin—breast cancer	1.61e-05	0.000233	CcSEcCtD
Norethindrone—Insomnia—Capecitabine—breast cancer	1.6e-05	0.000232	CcSEcCtD
Norethindrone—Rash—Fluorouracil—breast cancer	1.6e-05	0.000231	CcSEcCtD
Norethindrone—Dermatitis—Fluorouracil—breast cancer	1.59e-05	0.000231	CcSEcCtD
Norethindrone—Hypersensitivity—Paclitaxel—breast cancer	1.59e-05	0.00023	CcSEcCtD
Norethindrone—Headache—Fluorouracil—breast cancer	1.59e-05	0.00023	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Docetaxel—breast cancer	1.58e-05	0.000229	CcSEcCtD
Norethindrone—Connective tissue disorder—Doxorubicin—breast cancer	1.58e-05	0.000229	CcSEcCtD
Norethindrone—Fatigue—Docetaxel—breast cancer	1.58e-05	0.000228	CcSEcCtD
Norethindrone—Nausea—Mitoxantrone—breast cancer	1.57e-05	0.000228	CcSEcCtD
Norethindrone—Nausea—Irinotecan—breast cancer	1.57e-05	0.000228	CcSEcCtD
Norethindrone—Immune system disorder—Epirubicin—breast cancer	1.57e-05	0.000227	CcSEcCtD
Norethindrone—Dyspepsia—Capecitabine—breast cancer	1.56e-05	0.000226	CcSEcCtD
Norethindrone—Progesterone—SHBG—breast cancer	1.56e-05	0.0065	CrCbGaD
Norethindrone—Progesterone—CYP1B1—breast cancer	1.56e-05	0.0065	CrCbGaD
Norethindrone—Asthenia—Paclitaxel—breast cancer	1.55e-05	0.000224	CcSEcCtD
Norethindrone—Alopecia—Epirubicin—breast cancer	1.53e-05	0.000222	CcSEcCtD
Norethindrone—Nausea—Gemcitabine—breast cancer	1.53e-05	0.000222	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Capecitabine—breast cancer	1.53e-05	0.000221	CcSEcCtD
Norethindrone—Fatigue—Capecitabine—breast cancer	1.53e-05	0.000221	CcSEcCtD
Norethindrone—Pruritus—Paclitaxel—breast cancer	1.53e-05	0.000221	CcSEcCtD
Norethindrone—Mental disorder—Epirubicin—breast cancer	1.52e-05	0.00022	CcSEcCtD
Norethindrone—Erythema multiforme—Doxorubicin—breast cancer	1.52e-05	0.00022	CcSEcCtD
Norethindrone—Nausea—Fluorouracil—breast cancer	1.5e-05	0.000218	CcSEcCtD
Norethindrone—Gastrointestinal pain—Docetaxel—breast cancer	1.49e-05	0.000217	CcSEcCtD
Norethindrone—Flatulence—Epirubicin—breast cancer	1.49e-05	0.000216	CcSEcCtD
Norethindrone—Tension—Epirubicin—breast cancer	1.48e-05	0.000215	CcSEcCtD
Norethindrone—Testosterone—SHBG—breast cancer	1.47e-05	0.00614	CrCbGaD
Norethindrone—Testosterone—CYP1B1—breast cancer	1.47e-05	0.00614	CrCbGaD
Norethindrone—Nervousness—Epirubicin—breast cancer	1.47e-05	0.000213	CcSEcCtD
Norethindrone—Immune system disorder—Doxorubicin—breast cancer	1.45e-05	0.00021	CcSEcCtD
Norethindrone—Gastrointestinal pain—Capecitabine—breast cancer	1.45e-05	0.00021	CcSEcCtD
Norethindrone—Abdominal pain—Docetaxel—breast cancer	1.44e-05	0.000209	CcSEcCtD
Norethindrone—Dizziness—Paclitaxel—breast cancer	1.43e-05	0.000207	CcSEcCtD
Norethindrone—Alopecia—Doxorubicin—breast cancer	1.42e-05	0.000206	CcSEcCtD
Norethindrone—Mental disorder—Doxorubicin—breast cancer	1.41e-05	0.000204	CcSEcCtD
Norethindrone—Urticaria—Capecitabine—breast cancer	1.41e-05	0.000204	CcSEcCtD
Norethindrone—Abdominal pain—Capecitabine—breast cancer	1.4e-05	0.000203	CcSEcCtD
Norethindrone—Convulsion—Methotrexate—breast cancer	1.4e-05	0.000203	CcSEcCtD
Norethindrone—Flatulence—Doxorubicin—breast cancer	1.38e-05	0.0002	CcSEcCtD
Norethindrone—Tension—Doxorubicin—breast cancer	1.37e-05	0.000199	CcSEcCtD
Norethindrone—Vomiting—Paclitaxel—breast cancer	1.37e-05	0.000199	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.36e-05	0.000198	CcSEcCtD
Norethindrone—Progesterone—AR—breast cancer	1.36e-05	0.0057	CrCbGaD
Norethindrone—Drospirenone—PTGS2—breast cancer	1.36e-05	0.00569	CrCbGaD
Norethindrone—Rash—Paclitaxel—breast cancer	1.36e-05	0.000197	CcSEcCtD
Norethindrone—Dermatitis—Paclitaxel—breast cancer	1.36e-05	0.000197	CcSEcCtD
Norethindrone—Nervousness—Doxorubicin—breast cancer	1.36e-05	0.000197	CcSEcCtD
Norethindrone—Headache—Paclitaxel—breast cancer	1.35e-05	0.000196	CcSEcCtD
Norethindrone—Hypersensitivity—Docetaxel—breast cancer	1.35e-05	0.000195	CcSEcCtD
Norethindrone—Anaphylactic shock—Methotrexate—breast cancer	1.32e-05	0.000191	CcSEcCtD
Norethindrone—Hydrocortisone—ABCG2—breast cancer	1.32e-05	0.0055	CrCbGaD
Norethindrone—Asthenia—Docetaxel—breast cancer	1.31e-05	0.00019	CcSEcCtD
Norethindrone—Convulsion—Epirubicin—breast cancer	1.31e-05	0.00019	CcSEcCtD
Norethindrone—Hypersensitivity—Capecitabine—breast cancer	1.3e-05	0.000189	CcSEcCtD
Norethindrone—Pruritus—Docetaxel—breast cancer	1.29e-05	0.000187	CcSEcCtD
Norethindrone—Testosterone—AR—breast cancer	1.29e-05	0.00539	CrCbGaD
Norethindrone—Nausea—Paclitaxel—breast cancer	1.28e-05	0.000186	CcSEcCtD
Norethindrone—Skin disorder—Methotrexate—breast cancer	1.28e-05	0.000185	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.28e-05	0.000185	CcSEcCtD
Norethindrone—Asthenia—Capecitabine—breast cancer	1.27e-05	0.000184	CcSEcCtD
Norethindrone—Pruritus—Capecitabine—breast cancer	1.25e-05	0.000181	CcSEcCtD
Norethindrone—Anaphylactic shock—Epirubicin—breast cancer	1.23e-05	0.000179	CcSEcCtD
Norethindrone—Oedema—Epirubicin—breast cancer	1.23e-05	0.000179	CcSEcCtD
Norethindrone—Convulsion—Doxorubicin—breast cancer	1.21e-05	0.000175	CcSEcCtD
Norethindrone—Dizziness—Docetaxel—breast cancer	1.21e-05	0.000175	CcSEcCtD
Norethindrone—Skin disorder—Epirubicin—breast cancer	1.2e-05	0.000173	CcSEcCtD
Norethindrone—Insomnia—Methotrexate—breast cancer	1.19e-05	0.000173	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.18e-05	0.000171	CcSEcCtD
Norethindrone—Somnolence—Methotrexate—breast cancer	1.17e-05	0.00017	CcSEcCtD
Norethindrone—Dizziness—Capecitabine—breast cancer	1.17e-05	0.00017	CcSEcCtD
Norethindrone—Vomiting—Docetaxel—breast cancer	1.16e-05	0.000168	CcSEcCtD
Norethindrone—Dyspepsia—Methotrexate—breast cancer	1.16e-05	0.000168	CcSEcCtD
Norethindrone—Rash—Docetaxel—breast cancer	1.15e-05	0.000167	CcSEcCtD
Norethindrone—Dermatitis—Docetaxel—breast cancer	1.15e-05	0.000167	CcSEcCtD
Norethindrone—Headache—Docetaxel—breast cancer	1.14e-05	0.000166	CcSEcCtD
Norethindrone—Anaphylactic shock—Doxorubicin—breast cancer	1.14e-05	0.000165	CcSEcCtD
Norethindrone—Oedema—Doxorubicin—breast cancer	1.14e-05	0.000165	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methotrexate—breast cancer	1.14e-05	0.000165	CcSEcCtD
Norethindrone—Levonorgestrel—CYP3A4—breast cancer	1.14e-05	0.00474	CrCbGaD
Norethindrone—Fatigue—Methotrexate—breast cancer	1.14e-05	0.000165	CcSEcCtD
Norethindrone—Vomiting—Capecitabine—breast cancer	1.12e-05	0.000163	CcSEcCtD
Norethindrone—Rash—Capecitabine—breast cancer	1.12e-05	0.000162	CcSEcCtD
Norethindrone—Insomnia—Epirubicin—breast cancer	1.11e-05	0.000162	CcSEcCtD
Norethindrone—Dermatitis—Capecitabine—breast cancer	1.11e-05	0.000162	CcSEcCtD
Norethindrone—Headache—Capecitabine—breast cancer	1.11e-05	0.000161	CcSEcCtD
Norethindrone—Skin disorder—Doxorubicin—breast cancer	1.11e-05	0.000161	CcSEcCtD
Norethindrone—Somnolence—Epirubicin—breast cancer	1.1e-05	0.000159	CcSEcCtD
Norethindrone—Nausea—Docetaxel—breast cancer	1.09e-05	0.000157	CcSEcCtD
Norethindrone—Dyspepsia—Epirubicin—breast cancer	1.08e-05	0.000157	CcSEcCtD
Norethindrone—Testosterone—CYP19A1—breast cancer	1.08e-05	0.00451	CrCbGaD
Norethindrone—Gastrointestinal pain—Methotrexate—breast cancer	1.08e-05	0.000156	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Epirubicin—breast cancer	1.06e-05	0.000154	CcSEcCtD
Norethindrone—Fatigue—Epirubicin—breast cancer	1.06e-05	0.000154	CcSEcCtD
Norethindrone—Progesterone—ESR1—breast cancer	1.05e-05	0.00439	CrCbGaD
Norethindrone—Nausea—Capecitabine—breast cancer	1.05e-05	0.000152	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—breast cancer	1.05e-05	0.000152	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—breast cancer	1.04e-05	0.000151	CcSEcCtD
Norethindrone—Danazol—CYP3A4—breast cancer	1.03e-05	0.00432	CrCbGaD
Norethindrone—Insomnia—Doxorubicin—breast cancer	1.03e-05	0.000149	CcSEcCtD
Norethindrone—Testosterone—ABCG2—breast cancer	1.01e-05	0.00424	CrCbGaD
Norethindrone—Somnolence—Doxorubicin—breast cancer	1.01e-05	0.000147	CcSEcCtD
Norethindrone—Gastrointestinal pain—Epirubicin—breast cancer	1.01e-05	0.000146	CcSEcCtD
Norethindrone—Dyspepsia—Doxorubicin—breast cancer	1e-05	0.000145	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Doxorubicin—breast cancer	9.85e-06	0.000143	CcSEcCtD
Norethindrone—Fatigue—Doxorubicin—breast cancer	9.83e-06	0.000142	CcSEcCtD
Norethindrone—Urticaria—Epirubicin—breast cancer	9.79e-06	0.000142	CcSEcCtD
Norethindrone—Abdominal pain—Epirubicin—breast cancer	9.74e-06	0.000141	CcSEcCtD
Norethindrone—Hypersensitivity—Methotrexate—breast cancer	9.7e-06	0.000141	CcSEcCtD
Norethindrone—Ethinyl Estradiol—CYP3A4—breast cancer	9.57e-06	0.004	CrCbGaD
Norethindrone—Asthenia—Methotrexate—breast cancer	9.45e-06	0.000137	CcSEcCtD
Norethindrone—Gastrointestinal pain—Doxorubicin—breast cancer	9.33e-06	0.000135	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—breast cancer	9.32e-06	0.000135	CcSEcCtD
Norethindrone—Hypersensitivity—Epirubicin—breast cancer	9.08e-06	0.000132	CcSEcCtD
Norethindrone—Urticaria—Doxorubicin—breast cancer	9.06e-06	0.000131	CcSEcCtD
Norethindrone—Abdominal pain—Doxorubicin—breast cancer	9.02e-06	0.000131	CcSEcCtD
Norethindrone—Asthenia—Epirubicin—breast cancer	8.84e-06	0.000128	CcSEcCtD
Norethindrone—Methyltestosterone—CYP3A4—breast cancer	8.74e-06	0.00365	CrCbGaD
Norethindrone—Pruritus—Epirubicin—breast cancer	8.72e-06	0.000126	CcSEcCtD
Norethindrone—Dizziness—Methotrexate—breast cancer	8.71e-06	0.000126	CcSEcCtD
Norethindrone—Hypersensitivity—Doxorubicin—breast cancer	8.4e-06	0.000122	CcSEcCtD
Norethindrone—Progesterone—CYP1A1—breast cancer	8.4e-06	0.00351	CrCbGaD
Norethindrone—Vomiting—Methotrexate—breast cancer	8.37e-06	0.000121	CcSEcCtD
Norethindrone—Rash—Methotrexate—breast cancer	8.3e-06	0.00012	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—breast cancer	8.3e-06	0.00012	CcSEcCtD
Norethindrone—Headache—Methotrexate—breast cancer	8.25e-06	0.00012	CcSEcCtD
Norethindrone—Asthenia—Doxorubicin—breast cancer	8.18e-06	0.000119	CcSEcCtD
Norethindrone—Dizziness—Epirubicin—breast cancer	8.15e-06	0.000118	CcSEcCtD
Norethindrone—Pruritus—Doxorubicin—breast cancer	8.07e-06	0.000117	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ABCB1—breast cancer	7.97e-06	0.00333	CrCbGaD
Norethindrone—Testosterone—CYP1A1—breast cancer	7.94e-06	0.00332	CrCbGaD
Norethindrone—Vomiting—Epirubicin—breast cancer	7.84e-06	0.000114	CcSEcCtD
Norethindrone—Nausea—Methotrexate—breast cancer	7.82e-06	0.000113	CcSEcCtD
Norethindrone—Rash—Epirubicin—breast cancer	7.77e-06	0.000113	CcSEcCtD
Norethindrone—Dermatitis—Epirubicin—breast cancer	7.76e-06	0.000113	CcSEcCtD
Norethindrone—Headache—Epirubicin—breast cancer	7.72e-06	0.000112	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—breast cancer	7.62e-06	0.00318	CrCbGaD
Norethindrone—Dizziness—Doxorubicin—breast cancer	7.54e-06	0.000109	CcSEcCtD
Norethindrone—Nausea—Epirubicin—breast cancer	7.32e-06	0.000106	CcSEcCtD
Norethindrone—Vomiting—Doxorubicin—breast cancer	7.25e-06	0.000105	CcSEcCtD
Norethindrone—Rash—Doxorubicin—breast cancer	7.19e-06	0.000104	CcSEcCtD
Norethindrone—Dermatitis—Doxorubicin—breast cancer	7.18e-06	0.000104	CcSEcCtD
Norethindrone—Headache—Doxorubicin—breast cancer	7.14e-06	0.000104	CcSEcCtD
Norethindrone—Nausea—Doxorubicin—breast cancer	6.77e-06	9.82e-05	CcSEcCtD
Norethindrone—Hydrocortisone—CYP3A4—breast cancer	6.58e-06	0.00275	CrCbGaD
Norethindrone—Progesterone—CYP2D6—breast cancer	6.25e-06	0.00261	CrCbGaD
Norethindrone—Hydrocortisone—ABCB1—breast cancer	5.48e-06	0.00229	CrCbGaD
Norethindrone—Progesterone—CYP3A4—breast cancer	5.36e-06	0.00224	CrCbGaD
Norethindrone—Testosterone—CYP3A4—breast cancer	5.07e-06	0.00212	CrCbGaD
Norethindrone—Progesterone—ABCB1—breast cancer	4.46e-06	0.00186	CrCbGaD
Norethindrone—Testosterone—ALB—breast cancer	4.42e-06	0.00185	CrCbGaD
Norethindrone—Testosterone—ABCB1—breast cancer	4.22e-06	0.00176	CrCbGaD
Norethindrone—CYP2C19—Metabolism—ENO1—breast cancer	1.79e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS1—breast cancer	1.79e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.79e-06	6.23e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CAV1—breast cancer	1.78e-06	6.2e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A1—breast cancer	1.77e-06	6.18e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NQO1—breast cancer	1.77e-06	6.18e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP17A1—breast cancer	1.77e-06	6.16e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.76e-06	6.15e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2D6—breast cancer	1.76e-06	6.13e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL8—breast cancer	1.75e-06	6.11e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ENO1—breast cancer	1.75e-06	6.1e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS1—breast cancer	1.75e-06	6.1e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—breast cancer	1.75e-06	6.1e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA3—breast cancer	1.75e-06	6.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCC1—breast cancer	1.75e-06	6.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMMR—breast cancer	1.75e-06	6.08e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.73e-06	6.05e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP3A4—breast cancer	1.73e-06	6.02e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOA2—breast cancer	1.73e-06	6.02e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—COMT—breast cancer	1.72e-06	6.01e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.72e-06	5.99e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2D6—breast cancer	1.72e-06	5.98e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—breast cancer	1.72e-06	5.98e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—breast cancer	1.71e-06	5.96e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1B1—breast cancer	1.7e-06	5.92e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—breast cancer	1.69e-06	5.9e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.69e-06	5.89e-05	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.69e-06	5.89e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ITPR1—breast cancer	1.69e-06	5.89e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOA2—breast cancer	1.68e-06	5.87e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—breast cancer	1.68e-06	5.84e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FASN—breast cancer	1.67e-06	5.84e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—breast cancer	1.67e-06	5.84e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BCHE—breast cancer	1.67e-06	5.81e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HSP90AA1—breast cancer	1.67e-06	5.81e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC5A5—breast cancer	1.65e-06	5.74e-05	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.64e-06	5.71e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FASN—breast cancer	1.63e-06	5.7e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—breast cancer	1.63e-06	5.69e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—breast cancer	1.63e-06	5.68e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BCHE—breast cancer	1.63e-06	5.67e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—breast cancer	1.62e-06	5.66e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NCOA1—breast cancer	1.62e-06	5.65e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CG—breast cancer	1.62e-06	5.65e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—breast cancer	1.62e-06	5.63e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC5A5—breast cancer	1.61e-06	5.6e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—STK11—breast cancer	1.6e-06	5.57e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP19A1—breast cancer	1.6e-06	5.57e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA9—breast cancer	1.6e-06	5.57e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA4—breast cancer	1.6e-06	5.57e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TYMS—breast cancer	1.59e-06	5.56e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NQO1—breast cancer	1.59e-06	5.54e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A1—breast cancer	1.59e-06	5.54e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—breast cancer	1.58e-06	5.52e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—breast cancer	1.58e-06	5.5e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLA2G4A—breast cancer	1.58e-06	5.5e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—breast cancer	1.58e-06	5.5e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NCOR1—breast cancer	1.58e-06	5.5e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTEN—breast cancer	1.57e-06	5.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.56e-06	5.43e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX2—breast cancer	1.56e-06	5.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA2—breast cancer	1.56e-06	5.42e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NQO1—breast cancer	1.55e-06	5.41e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A1—breast cancer	1.55e-06	5.41e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP3A4—breast cancer	1.55e-06	5.41e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.54e-06	5.38e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—breast cancer	1.54e-06	5.37e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SULT1A1—breast cancer	1.54e-06	5.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX4—breast cancer	1.54e-06	5.36e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SRC—breast cancer	1.53e-06	5.32e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1B1—breast cancer	1.52e-06	5.32e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP3A4—breast cancer	1.51e-06	5.28e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—breast cancer	1.51e-06	5.26e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—IDH1—breast cancer	1.5e-06	5.23e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA1—breast cancer	1.5e-06	5.23e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.5e-06	5.23e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.5e-06	5.21e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP1A1—breast cancer	1.49e-06	5.21e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1B1—breast cancer	1.49e-06	5.19e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—breast cancer	1.49e-06	5.18e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—COMT—breast cancer	1.48e-06	5.18e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NAT2—breast cancer	1.48e-06	5.17e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ERCC2—breast cancer	1.48e-06	5.17e-05	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.48e-06	5.16e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—breast cancer	1.48e-06	5.15e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SRC—breast cancer	1.46e-06	5.09e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HSP90AA1—breast cancer	1.46e-06	5.09e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—breast cancer	1.46e-06	5.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOA1—breast cancer	1.45e-06	5.07e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ITPR1—breast cancer	1.45e-06	5.07e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—STK11—breast cancer	1.43e-06	5e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP19A1—breast cancer	1.43e-06	5e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CD—breast cancer	1.42e-06	4.96e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—breast cancer	1.42e-06	4.96e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOA1—breast cancer	1.42e-06	4.95e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—breast cancer	1.41e-06	4.91e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK3—breast cancer	1.41e-06	4.9e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—breast cancer	1.41e-06	4.9e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—STK11—breast cancer	1.4e-06	4.88e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP19A1—breast cancer	1.4e-06	4.88e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—breast cancer	1.4e-06	4.88e-05	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—breast cancer	1.4e-06	4.87e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—breast cancer	1.39e-06	4.86e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TYMS—breast cancer	1.37e-06	4.79e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—breast cancer	1.36e-06	4.76e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLA2G4A—breast cancer	1.36e-06	4.73e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—breast cancer	1.36e-06	4.73e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NCOR1—breast cancer	1.36e-06	4.73e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK3—breast cancer	1.35e-06	4.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.35e-06	4.69e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—breast cancer	1.34e-06	4.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—COMT—breast cancer	1.33e-06	4.65e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—breast cancer	1.33e-06	4.62e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—breast cancer	1.31e-06	4.56e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—breast cancer	1.31e-06	4.56e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—breast cancer	1.31e-06	4.55e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ITPR1—breast cancer	1.31e-06	4.55e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MED12—breast cancer	1.3e-06	4.54e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DPYD—breast cancer	1.3e-06	4.54e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—COMT—breast cancer	1.3e-06	4.53e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—breast cancer	1.3e-06	4.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—breast cancer	1.29e-06	4.51e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1A1—breast cancer	1.29e-06	4.49e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAV1—breast cancer	1.29e-06	4.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDOA—breast cancer	1.28e-06	4.47e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGFR—breast cancer	1.28e-06	4.46e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—breast cancer	1.28e-06	4.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ERCC2—breast cancer	1.28e-06	4.45e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ITPR1—breast cancer	1.27e-06	4.44e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—breast cancer	1.26e-06	4.41e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—breast cancer	1.26e-06	4.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA3—breast cancer	1.24e-06	4.34e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CB—breast cancer	1.24e-06	4.33e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A2—breast cancer	1.23e-06	4.3e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TYMS—breast cancer	1.23e-06	4.3e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—breast cancer	1.23e-06	4.29e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.22e-06	4.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOR1—breast cancer	1.22e-06	4.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—breast cancer	1.22e-06	4.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTR—breast cancer	1.21e-06	4.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCG2—breast cancer	1.21e-06	4.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CPT1A—breast cancer	1.21e-06	4.22e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—breast cancer	1.21e-06	4.22e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TYMS—breast cancer	1.2e-06	4.2e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—breast cancer	1.2e-06	4.18e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLA2G4A—breast cancer	1.19e-06	4.15e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—breast cancer	1.19e-06	4.15e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOR1—breast cancer	1.19e-06	4.15e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HPGDS—breast cancer	1.19e-06	4.14e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HBA1—breast cancer	1.18e-06	4.11e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CG—breast cancer	1.17e-06	4.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—breast cancer	1.17e-06	4.07e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—breast cancer	1.16e-06	4.05e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1A1—breast cancer	1.16e-06	4.03e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACHE—breast cancer	1.15e-06	4.01e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—breast cancer	1.15e-06	4.01e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ERCC2—breast cancer	1.15e-06	4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—breast cancer	1.14e-06	3.97e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1A1—breast cancer	1.13e-06	3.93e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—breast cancer	1.12e-06	3.92e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ERCC2—breast cancer	1.12e-06	3.9e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—breast cancer	1.11e-06	3.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAV1—breast cancer	1.11e-06	3.86e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP17A1—breast cancer	1.09e-06	3.8e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS1—breast cancer	1.08e-06	3.76e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ENO1—breast cancer	1.08e-06	3.76e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—breast cancer	1.08e-06	3.76e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—breast cancer	1.07e-06	3.75e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HRAS—breast cancer	1.07e-06	3.75e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTEN—breast cancer	1.07e-06	3.74e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.06e-06	3.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2D6—breast cancer	1.06e-06	3.69e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—breast cancer	1.05e-06	3.67e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA2—breast cancer	1.04e-06	3.62e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CD—breast cancer	1.03e-06	3.59e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HRAS—breast cancer	1.03e-06	3.58e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—breast cancer	1.02e-06	3.54e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CG—breast cancer	1.01e-06	3.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FASN—breast cancer	1.01e-06	3.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BCHE—breast cancer	1e-06	3.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAV1—breast cancer	9.94e-07	3.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC5A5—breast cancer	9.9e-07	3.45e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—breast cancer	9.84e-07	3.43e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—breast cancer	9.72e-07	3.39e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAV1—breast cancer	9.7e-07	3.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NQO1—breast cancer	9.56e-07	3.33e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A1—breast cancer	9.56e-07	3.33e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.49e-07	3.31e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—breast cancer	9.49e-07	3.31e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1B1—breast cancer	9.17e-07	3.2e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—breast cancer	9.08e-07	3.16e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CG—breast cancer	9.05e-07	3.16e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSP90AA1—breast cancer	8.99e-07	3.13e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CB—breast cancer	8.97e-07	3.13e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—breast cancer	8.89e-07	3.1e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CD—breast cancer	8.86e-07	3.09e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CG—breast cancer	8.83e-07	3.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA1—breast cancer	8.75e-07	3.05e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP19A1—breast cancer	8.62e-07	3.01e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—STK11—breast cancer	8.62e-07	3.01e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—breast cancer	8.37e-07	2.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—COMT—breast cancer	8.01e-07	2.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—breast cancer	7.98e-07	2.78e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CD—breast cancer	7.96e-07	2.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—breast cancer	7.87e-07	2.74e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—breast cancer	7.85e-07	2.74e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ITPR1—breast cancer	7.85e-07	2.74e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CD—breast cancer	7.77e-07	2.71e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTEN—breast cancer	7.75e-07	2.7e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CB—breast cancer	7.72e-07	2.69e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—breast cancer	7.67e-07	2.67e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—breast cancer	7.65e-07	2.67e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—breast cancer	7.56e-07	2.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—breast cancer	7.55e-07	2.63e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—breast cancer	7.51e-07	2.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TYMS—breast cancer	7.41e-07	2.59e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—breast cancer	7.33e-07	2.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOR1—breast cancer	7.33e-07	2.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—breast cancer	7.33e-07	2.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.33e-07	2.56e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—breast cancer	7.02e-07	2.45e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1A1—breast cancer	6.95e-07	2.42e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CB—breast cancer	6.93e-07	2.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ERCC2—breast cancer	6.89e-07	2.4e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—breast cancer	6.87e-07	2.4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CB—breast cancer	6.77e-07	2.36e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—breast cancer	6.71e-07	2.34e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTEN—breast cancer	6.68e-07	2.33e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—breast cancer	6.48e-07	2.26e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—breast cancer	6.18e-07	2.15e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTEN—breast cancer	5.99e-07	2.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAV1—breast cancer	5.97e-07	2.08e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTEN—breast cancer	5.85e-07	2.04e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—breast cancer	5.47e-07	1.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CG—breast cancer	5.44e-07	1.9e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CD—breast cancer	4.78e-07	1.67e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—breast cancer	4.72e-07	1.65e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—breast cancer	4.71e-07	1.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—breast cancer	4.52e-07	1.58e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—breast cancer	4.47e-07	1.56e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—breast cancer	4.23e-07	1.47e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CB—breast cancer	4.17e-07	1.45e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—breast cancer	4.13e-07	1.44e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—breast cancer	4.13e-07	1.44e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—breast cancer	3.85e-07	1.34e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTEN—breast cancer	3.6e-07	1.26e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—breast cancer	3.45e-07	1.2e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—breast cancer	3.37e-07	1.18e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—breast cancer	2.54e-07	8.86e-06	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—breast cancer	2.08e-07	7.24e-06	CbGpPWpGaD
